| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 6 | +66.67% | -2.81% | +0.41% | -3.22% | -3.96% | — |
| 14d | 6 | +50.00% | -2.89% | +0.85% | -3.74% | -1.74% | — |
| 30d | 6 | +50.00% | -0.02% | -0.71% | +1.44% | -0.83% | — |
| 60d | 6 | +33.33% | +5.27% | +4.24% | +1.03% | -0.36% | — |
| 90d | 6 | +33.33% | +8.99% | +5.94% | +4.81% | +11.03% | — |
| 180d | 6(1 pending) | +20.00% | +32.18% | +12.53% | +19.65% | +9.15% | — |
| 1y | 6(4 pending) | +0.00% | +78.09% | +24.36% | +53.74% | +53.74% | — |
| 2y | 6(6 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| BBIO BRIDGEBIO PHARMA, INC. | SALE Chief Accounting Officer | 4,714 | $79.86 | $376.5K | 122,687 | Aug 16, 2026 | Aug 18, 2026 ↗ | View → |
| BBIO BRIDGEBIO PHARMA, INC. | SALE10b5-1 10b5-1 plan | 2,000 | $80.06 | $160.1K | 127,401 | Jul 30, 2026 | Aug 3, 2026 ↗ | View → |
| BBIO BRIDGEBIO PHARMA, INC. | SALE Chief Accounting Officer | 4,714 | $66.13 | $311.7K | 129,401 | May 16, 2026 | May 19, 2026 ↗ | View → |
| BBIO BRIDGEBIO PHARMA, INC. | SALE10b5-1 10b5-1 plan | 2,000 | $71.58 | $143.2K | 134,115 | Apr 30, 2026 | May 4, 2026 ↗ | View → |
| BBIO BRIDGEBIO PHARMA, INC. | PURCHASEGRANT Stock grant | 14,170 | — | — | 136,115 | Mar 18, 2026 | Mar 20, 2026 ↗ | View → |
| BBIO BRIDGEBIO PHARMA, INC. | SALE10b5-1 10b5-1 plan | 2,000 | $66.00 | $132.0K | 121,945 | Feb 26, 2026 | Feb 27, 2026 ↗ | View → |
| BBIO BRIDGEBIO PHARMA, INC. | SALE10b5-1 10b5-1 plan | 510 | $74.31 | $37.9K | 123,945 | Feb 17, 2026 | Feb 18, 2026 ↗ | View → |
| BBIO BRIDGEBIO PHARMA, INC. | SALE Chief Accounting Officer | 4,349 | $75.25 | $327.3K | 124,455 | Feb 16, 2026 | Feb 18, 2026 ↗ | View → |
| BBIO BRIDGEBIO PHARMA, INC. | SALE Chief Accounting Officer | 2,003 | $75.15 | $150.5K | 128,294 | Dec 12, 2025 | Dec 16, 2025 ↗ | View → |
| BBIO BRIDGEBIO PHARMA, INC. | SALE10b5-1 10b5-1 plan | 2,000 | $74.26 | $148.5K | 130,297 | Dec 8, 2025 | Dec 10, 2025 ↗ | View → |
| BBIO BRIDGEBIO PHARMA, INC. | SALE Chief Accounting Officer | 4,781 | $66.39 | $317.4K | 132,297 | Nov 16, 2025 | Nov 18, 2025 ↗ | View → |
| BBIO BRIDGEBIO PHARMA, INC. | SALE Chief Accounting Officer | 4,781 | $51.32 | $245.4K | 137,078 | Aug 16, 2025 | Aug 19, 2025 ↗ | View → |
| BBIO BRIDGEBIO PHARMA, INC. | SALE Chief Accounting Officer | 1,000 | $45.44 | $45.4K | 141,859 | Aug 7, 2025 | Aug 11, 2025 ↗ | View → |
| BBIO BRIDGEBIO PHARMA, INC. | SALE Chief Accounting Officer | 4,780 | $33.84 | $161.8K | 142,859 | May 16, 2025 | May 20, 2025 ↗ | View → |
| BBIO BRIDGEBIO PHARMA, INC. | SALE Chief Accounting Officer | 1,026 | $38.51 | $39.5K | 147,639 | May 2, 2025 | May 6, 2025 ↗ | View → |
| BBIO BRIDGEBIO PHARMA, INC. | PURCHASEGRANT Stock grant | 23,660 | — | — | 148,665 | Mar 19, 2025 | Mar 21, 2025 ↗ | View → |